- Home
- FGL vs CVKD Comparison
FGL vs CVKD Comparison
Compare FGL & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGL
- CVKD
- Stock Information
- Founded
- FGL 2021
- CVKD 2022
- Country
- FGL Malaysia
- CVKD United States
- Employees
- FGL N/A
- CVKD N/A
- Industry
- FGL
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- FGL
- CVKD Health Care
- Exchange
- FGL NYSE
- CVKD Nasdaq
- Market Cap
- FGL 25.4M
- CVKD 29.5M
- IPO Year
- FGL 2024
- CVKD 2023
- Fundamental
- Price
- FGL $1.22
- CVKD $10.63
- Analyst Decision
- FGL
- CVKD Strong Buy
- Analyst Count
- FGL 0
- CVKD 1
- Target Price
- FGL N/A
- CVKD $32.00
- AVG Volume (30 Days)
- FGL 334.6K
- CVKD 28.9K
- Earning Date
- FGL 08-05-2025
- CVKD 08-06-2025
- Dividend Yield
- FGL N/A
- CVKD N/A
- EPS Growth
- FGL N/A
- CVKD N/A
- EPS
- FGL N/A
- CVKD N/A
- Revenue
- FGL $20,205,441.00
- CVKD N/A
- Revenue This Year
- FGL N/A
- CVKD N/A
- Revenue Next Year
- FGL N/A
- CVKD N/A
- P/E Ratio
- FGL N/A
- CVKD N/A
- Revenue Growth
- FGL N/A
- CVKD N/A
- 52 Week Low
- FGL $0.66
- CVKD $5.70
- 52 Week High
- FGL $5.26
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- FGL N/A
- CVKD 38.21
- Support Level
- FGL N/A
- CVKD $11.25
- Resistance Level
- FGL N/A
- CVKD $11.88
- Average True Range (ATR)
- FGL 0.00
- CVKD 0.76
- MACD
- FGL 0.00
- CVKD -0.02
- Stochastic Oscillator
- FGL 0.00
- CVKD 7.46
About FGL FOUNDER GROUP LTD
Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.